Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) shares advanced 0.21% in last trading session and ended the day at $4.88. And its has a return on assets of -354.70%. Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) quarterly performance is -56.47%.
Northwest Biotherapeutics (NASDAQ: NWBO) announced that the Company has entered into agreement for funding of $30 million from Woodford Investment Management in the UK (“Woodford”). Woodford will purchase $30 million of the Company’s common stock at $5.50 per share, for a total of 5,454,545 shares, raising Woodford’s total holdings to 25,915,937 shares, or about 28.1% of the Company. The purchase will take place in a closing on or before October 22, 2015.NW Bio also announced that it has engaged Ondra Partners (www.ondra.com), a London-based corporate finance firm with a focus on value creation and an integrated approach to medium and long term financing and related initiatives.
Park Electrochemical Corp. (NYSE:PKE) shares fell -1.45% in last trading session and ended the day at $16.34. PKE Gross Margin is 28.40% and its has a return on assets of 4.60%. Park Electrochemical Corp. (NYSE:PKE) quarterly performance is -6.04%.
Park Electrochemical Corp. (NYSE:PKE) announced that it plans to release its financial results for its 2016 fiscal year second quarter ended August 30, 2015 before the New York Stock Exchange opens on Wednesday, October 7, 2015. The Company will conduct a conference call to discuss such results at 11:00 a.m. EDT on the same day. Forward-looking and other material information may be discussed in this conference call.
On 30 October, YRC Worldwide Inc. (NASDAQ:YRCW) shares moved up 31.84% and was closed at $18.26. YRCW EPS growth in last 5 year was -40.74%. YRC Worldwide Inc. (NASDAQ:YRCW) year to date (YTD) performance is -18.81%.
YRC Worldwide Inc. (NASDAQ:YRCW) continued its slow, steady drive back into the black in the third quarter, reporting a net profit of $19.8 million, compared with a $1.2 million profit a year ago. For the first nine months of 2015, the less-than-truckload operator reported $24.2 million in net income, compared with a $73.9 million loss for the same period in 2014.YRC Freight, the third-largest stand-alone U.S. LTL carrier, nearly doubled its operating profit, raising it from $9 million a year ago to $17 million last quarter. Operating profit increased 38 percent from a year ago at the YRC regional LTL group, rising to $33.6 million.
Fifth Third Bancorp (NASDAQ:FITB) shares fell -2.16% in last trading session and ended the day at $19.05. And its has a return on assets of 1.00%. Fifth Third Bancorp (NASDAQ:FITB) quarterly performance is -9.02%.
Fifth Third Bancorp (NASDAQ:FITB) was downgraded by stock analysts at Stephens from an “overweight” rating to an “equal weight” rating in a report released on Monday.
Proteon Therapeutics Inc (NASDAQ:PRTO) caters to the Healthcare space. Its weekly performance is -8.12%. On the last day of trading company shares ended up at $13.70. Proteon Therapeutics Inc (NASDAQ:PRTO) distance from 50-day simple moving average (SMA50) is 5.27%.
Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular diseases, announced the appointment of S. Anthony (Tony) Kingsley to its Board of Directors. Mr. Kingsley has almost ten years of commercial operations experience in the healthcare industry and 15 years of experience as a Partner at McKinsey & Company focusing on the biotechnology, pharmaceutical and medical device industries. Mr. Kingsley was until recently the Executive Vice President, Global Commercial Operations at Biogen, Inc.
Leave a Reply